Cite
HARVARD Citation
O'Brien, B. et al. (n.d.). ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. Neuro-oncology. pp. vi14-vi15. [Online].